Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Disability in ALS
NCT00353665Phase 3Completed
- Sponsor
- Universidade de Lisboa
- Start
- Jul 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in amyotrophic lateral sclerosis (ALS), sponsored by Universidade de Lisboa. Started Jul 2005; status: completed.
02
Drugs
memantine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00353665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353665.